Cited by 247Monoclonal and Polyclonal Antibodies ResearchT-cell and B-cell Immunologyvaccines and immunoinformatics approaches

Observed antibody space: a resource for data mining next-generation sequencing of antibody repertoires

Open access
Kovaltsuk, Aleksandr, Leem, Jinwoo, Kelm, Sebastian, Snowden, James, Deane, Charlotte M, Krawczyk, Konrad·2018·The Journal of Immunology

Published version of a preprint

Abstract

Abs are immune system proteins that recognize noxious molecules for elimination. Their sequence diversity and binding versatility have made Abs the primary class of biopharmaceuticals. Recently, it has become possible to query their immense natural diversity using next-generation sequencing of Ig gene repertoires (Ig-seq). However, Ig-seq outputs are currently fragmented across repositories and tend to be presented as raw nucleotide reads, which means nontrivial effort is required to reuse the data for analysis. To address this issue, we have collected Ig-seq outputs from 55 studies, covering more than half a billion Ab sequences across diverse immune states, organisms (primarily human and mouse), and individuals. We have sorted, cleaned, annotated, translated, and numbered these sequences and make the data available via our Observed Antibody Space (OAS) resource at http://antibodymap.org The data within OAS will be regularly updated with newly released Ig-seq datasets. We believe OAS will facilitate data mining of immune repertoires for improved understanding of the immune system and development of better biotherapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1800708

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The increasing number of structural, sequence and experimental data on antibodies being deposited in the public domain provides the necessary foundation for improving data-driven methods.

    “The increasing number of structural [16], sequence [17] and experimental data [18–21] on antibodies being deposited in the public domain provides the necessary foundation for improving such data-driven methods.”
  • The field currently benefits from a steady stream of new data from NGS of B-cell Receptors and increasing resources for downloading such data.

    “In this respect, the field currently benefits from a steady stream of new data from NGS of B-cell Receptors (BCRs, to be used as proxy for antibodies) [212, 213] and there is an increasing number of resources available for downloading such data [17], which are being used to analyze therapeutic antibodies [13].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 96 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kovaltsuk, A., Leem, J., Kelm, S., Snowden, J., Deane, C. M., & Krawczyk, K.
Affiliations
  • University of Oxford (GB)
  • UCB Pharma (United Kingdom) (GB)
Corresponding author
  • Deane, Charlotte M
  • Krawczyk, Konrad
Venue
The Journal of Immunology
Published
2018-10
Volume
201
Issue
8
Pages
2502-2509
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2950118240
Cited by
247
References
96
Citations by year
2026: 34 · 2025: 46 · 2024: 48 · 2023: 33 · 2022: 33 · 2021: 21 · 2020: 17 · 2019: 12 · 2018: 3
FWCI
9.15
Type
journal article
Language
en
Open access
Locations
  • The Journal of Immunology (publishedVersion, other-oa)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council (1801486, BB/M011224, BB/M011224/1, M011224)
  • UCB Pharma
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
antibody repertoire, biologic therapy
MeSH terms
Animals, Antibodies, Antibody Diversity, Humans, Immunoglobulins, Immunotherapy, Databases, Genetic, Mice, Immunity, Humoral, Data Mining, Molecular Sequence Annotation, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review